Mostrar el registro sencillo del ítem

dc.contributor.authorSantana Otero, Antonio 
dc.contributor.authorHarper, A.
dc.contributor.authorTelling, L.
dc.contributor.authorOrtega Ponce, Daniel 
dc.contributor.authorCabrera, David
dc.contributor.otherFísica de la Materia Condensadaes_ES
dc.date.accessioned2024-06-19T09:24:12Z
dc.date.available2024-06-19T09:24:12Z
dc.date.issued2023
dc.identifier.issn2040-3372
dc.identifier.issn2040-3364
dc.identifier.urihttp://hdl.handle.net/10498/32650
dc.description.abstractBlood clotting disorders consisting of unwanted blood clot formation or excessive bleeding are some of the main causes of death worldwide. However, there are significant limitations in the current methods used to clinically monitor the dynamics of clot formation in human whole blood ex vivo. Here a new magnetic coagulometry platform for testing ex vivo coagulation is described. This platform exploits the sensitivity of the out-of-phase component of alternating current (AC) magnetic susceptibility (χ′′) to variations in mobility and agglomeration of magnetic nanoparticles when trapped during blood clot formation. By labelling human whole blood with magnetic nanoparticles, the out-of-phase component of AC magnetic susceptibility shows that the dynamics of blood clot formation correlates with a decrease in the out-of-phase component χ′′ over time activation of coagulation. This is caused by a rapid immobilisation of nanoparticles upon blood coagulation and compaction. In contrast, this rapid fall in the out-of-phase component χ′′ is significantly slowed down when blood is pre-treated with three different anticoagulant drugs. Remarkably, the system showed sensitivity towards the effect of clinically used direct oral anticoagulation (DOAC) drugs in whole blood coagulation, in contrast to the inability of clinical routine tests prothrombin time (PT) and partial thromboplastin time (PTT) to efficiently monitor this effect. Translation of this nanomagnetic approach into clinic can provide a superior method for monitoring blood coagulation and improve the efficiency of the current diagnostic techniques.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherROYAL SOC CHEMISTRYes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceNanoscale, Vol. 16, Núm. 7, 2023, pp. 3534-3548es_ES
dc.subjectROTATIONAL THROMBOELASTOMETRY ROTEMes_ES
dc.subjectINTRAVENOUS HEPARINes_ES
dc.subjectNANOPARTICLESes_ES
dc.subjectRIVAROXABANes_ES
dc.subjectBIVALIRUDINes_ES
dc.subjectHEMORRHAGEes_ES
dc.subjectTHERAPYes_ES
dc.subjectSAFETYes_ES
dc.subjectCOSTes_ES
dc.subjectTIMEes_ES
dc.titleMagnetic coagulometry: towards a new nanotechnological tool for ex vivo monitoring coagulation in human whole bloodes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1039/D3NR02593D
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2020-117544RB-I00/ES/NANOBOMBA TERMOFORETICA DIRIGIDA Y CELULAS CAR MONITORIZADAS POR NANOPARTICULAS COMO TERAPIA INMUNOLOGICA COMBINADA/ es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI//RED2018-102626-T es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI//RYC2018-025253-Ies_ES
dc.type.hasVersionVoRes_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Esta obra está bajo una Licencia Creative Commons Atribución 4.0 Internacional